Biodesix (BDSX) EBIT Margin (2019 - 2026)
Biodesix's (BDSX) quarterly EBIT Margin came in at 24.27% in Q1 2026, up 2661.0% YoY from 0.88% in Q1 2025, and down 254.73% on a QoQ basis from 6.84% in Q4 2025.
Biodesix (BDSX) EBIT Margin (2019 - 2026) Analysis & Trends
Biodesix (BDSX) has 8 years of EBIT Margin data on file, last reported at 24.27% in Q1 2026.
- Quarterly EBIT Margin rose 2661.0% year-over-year to 24.27% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 25.95% (up 1785.0% YoY) and the FY2025 annual result came in at 31.5%, up 1687.0% from the prior year.
- EBIT Margin fell to 24.27% in Q1 2026, from 6.84% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 6.84% in Q4 2025 to a low of 220.85% in Q1 2022.
- A 5-year average of 76.65% and a median of 50.87% in 2025 frame the typical range for EBIT Margin.
- Annual changes were most pronounced in 2022 — EBIT Margin plunged 20150 bps — and 2024, when it jumped 10642 bps.
- Tracing BDSX's EBIT Margin over 5 years: stood at 144.58% in 2022, then jumped by 68 bps to 46.84% in 2023, then soared by 31 bps to 32.55% in 2024, then surged by 79 bps to 6.84% in 2025, then plunged by 255 bps to 24.27% in 2026.
- The last three EBIT Margin figures came in at 24.27% (Q1 2026), 6.84% (Q4 2025), and 32.39% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 17.99% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -10.07% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 21.74% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 11.58% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 34.98% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 21.14% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 31.97% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 12.10% |
| 10 | Biodesix | 292.51 Mn | 262.51 Mn | 22.04 Mn | -20.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -20.06% |
| Mar 31, 2026 | -24.27% |
| Dec 31, 2025 | -6.84% |
| Sep 30, 2025 | -32.39% |
| Jun 30, 2025 | -48.55% |
| Mar 31, 2025 | -50.87% |
| Dec 31, 2024 | -32.55% |
| Sep 30, 2024 | -47.33% |
| Jun 30, 2024 | -45.95% |
| Mar 31, 2024 | -74.38% |
| Dec 31, 2023 | -46.84% |
| Sep 30, 2023 | -53.16% |
| Jun 30, 2023 | -92.04% |
| Mar 31, 2023 | -180.80% |
| Dec 31, 2022 | -144.58% |
| Sep 30, 2022 | -95.53% |
| Jun 30, 2022 | -106.17% |
| Mar 31, 2022 | -220.85% |
| Dec 31, 2021 | -161.67% |
| Sep 30, 2021 | -200.44% |